Novel immunomodulatory drugs and neo-substrates | Biomarker Research | Full Text
Mechanism of action of CRL4 CRBN E3 ubiquitin ligase and its effects... | Download Scientific Diagram
Cereblon versus VHL: Hijacking E3 ligases against each other using PROTACs - ScienceDirect
Controversy regarding the functional conservation of cereblon CUL4-type E3 ligase substrate receptor
CME: Mezigdomide (CC-92480), a Potent, Novel Cereblon E3 Ligase Modulator, Combined With Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma: Preliminary Results From the Dose-Expansion Phase of the CC-92480-MM-001 Trial Medical ...
Evolution of Cereblon-Mediated Protein Degradation as a Therapeutic Modality | ACS Medicinal Chemistry Letters
Novel immunomodulatory drugs and neo-substrates | Biomarker Research | Full Text
Cereblon E3 Ligase Modulators – BMS
Cancers | Free Full-Text | Rapid Progress in the Use of Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in the Treatment of Multiple Myeloma
Cereblon: promise and challenges for combating human diseases | SpringerLink
Frontiers | Cereblon-Based Small-Molecule Compounds to Control Neural Stem Cell Proliferation in Regenerative Medicine
Key regulators of sensitivity to immunomodulatory drugs in cancer treatment | Biomarker Research | Full Text
Cancers | Free Full-Text | Rapid Progress in the Use of Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in the Treatment of Multiple Myeloma
CC-90009, a novel cereblon E3 ligase modulator, targets acute myeloid leukemia blasts and leukemia stem cells - ScienceDirect
SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate | Nature Chemical Biology
Frontiers | Cereblon-Based Small-Molecule Compounds to Control Neural Stem Cell Proliferation in Regenerative Medicine
Discovery of CRBN E3 Ligase Modulator CC-92480 for the Treatment of Relapsed and Refractory Multiple Myeloma | Journal of Medicinal Chemistry
The E3 ligase adapter cereblon targets the C-terminal cyclic imide degron | Nature
A Cell-Based Target Engagement Assay for the Identification of Cereblon E3 Ubiquitin Ligase Ligands and Their Application in HDAC6 Degraders - ScienceDirect
CC-90009: A Cereblon E3 Ligase Modulating Drug That Promotes Selective Degradation of GSPT1 for the Treatment of Acute Myeloid Leukemia | Journal of Medicinal Chemistry
Development of targeted protein degradation therapeutics | Nature Chemical Biology
Molecular mechanism of action of cereblon E3 ligase modulators in... | Download Scientific Diagram
Molecular glue CELMoD compounds are regulators of cereblon conformation | Science
